CANCERGENIE

Welcome to the Brand page for “CANCERGENIE”, which is offered here for Cancer genie;computer software, optical disc media, and other electronic media providing gene expression profile information for use in predicting cancer, selecting therapeutics, evaluating efficacy and toxicity of treatments, and evaluating treatment programs; diagnostic devices for selecting therapeutics, evaluating efficacy and toxicity of a therapeutic treatment regime, and evaluating treatment of cancer; point-of-care equipment for carrying out and/or evaluation of medical-diagnostic examinations related to cancer; diagnostic devices for clinical, laboratory, or medical use to diagnose, prognose, predict or evaluate cancer ; computer software, optical disc media, and other electronic media providing gene expression profile information for use in predicting cancer, selecting therapeutics, evaluating efficacy and toxicity of treatments, and evaluating treatment programs; diagnostic devices for selecting therapeutics, evaluating efficacy and toxicity of a therapeutic treatment regime, and evaluating treatment of cancer; point-of-care equipment for carrying out and/or evaluation of medical-diagnostic examinations related to cancer; diagnostic devices for clinical, laboratory, or medical use to diagnose, prognose, predict or evaluate cancer;.

Its status is currently believed to be active. Its class is unavailable. “CANCERGENIE” is believed to be currently owned by “ChondroGene Limited”.

Owner:
CHONDROGENE LIMITED
Owner Details
Description:
CANCER GENIE;computer software, optical disc media, and other electronic media providing gene expression profile information for use in predicting cancer, selecting therapeutics, evaluating efficacy and toxicity of treatments, and evaluating treatment programs; diagnostic devices for selecting therapeutics, evaluating efficacy and toxicity of a therapeutic treatment regime, and evaluating treatment of cancer; point-of-care equipment for carrying out and/or evaluation of medical-diagnostic examinations related to cancer; diagnostic devices for clinical, laboratory, or medical use to diagnose, prognose, predict or evaluate cancer ; computer software, optical disc media, and other electronic media providing gene expression profile information for use in predicting cancer, selecting therapeutics, evaluating efficacy and toxicity of treatments, and evaluating treatment programs; diagnostic devices for selecting therapeutics, evaluating efficacy and toxicity of a therapeutic treatment regime, and evaluating treatment of cancer; point-of-care equipment for carrying out and/or evaluation of medical-diagnostic examinations related to cancer; diagnostic devices for clinical, laboratory, or medical use to diagnose, prognose, predict or evaluate cancer;
Categories: CANCER GENIE